Prediction of Staphylococcus aureus Antimicrobial Resistance by Whole-Genome Sequencing
暂无分享,去创建一个
Daniel J. Wilson | R. Everitt | A. Walker | T. Peto | D. Crook | T. Golubchik | N. Gordon | A. Kearns | J. Paul | B. Young | K. Cole | J. Price | M. Llewelyn | D. Wilson | B. Pichon | J. Finney | John M Finney | M. Morgan | A. S. Walker | D. J. Wilson | T. E. A. Peto | D. W. Crook | J. Paul | N. C. Gordon | B. Pichon | T. Golubchik | J. Paul | K. Cole | J. R. Price | A. M. Kearns | R. Everitt | M. Morgan | J. Finney | B. Young | M. J. Llewelyn | A. Walker | Tanya Golubchik
[1] A. Whitelaw,et al. Genetic basis of rifampicin resistance in methicillin-resistant Staphylococcus aureus suggests clonal expansion in hospitals in Cape Town, South Africa , 2012, BMC Microbiology.
[2] S. Rasmussen,et al. Identification of acquired antimicrobial resistance genes , 2012, The Journal of antimicrobial chemotherapy.
[3] A. Kwon,et al. Extended Spectrum of Quinolone Resistance, Even to a Potential Latter Third-Generation Agent, as a Result of a Minimum of Two GrlA and Two GyrA Alterations in Quinolone-Resistant Staphylococcus aureus , 2010, Chemotherapy.
[4] E. Birney,et al. Velvet: algorithms for de novo short read assembly using de Bruijn graphs. , 2008, Genome research.
[5] F. Tubau,et al. Molecular characterization of resistance to Rifampicin in an emerging hospital-associated Methicillin-resistant Staphylococcus aureus clone ST228, Spain , 2010, BMC Microbiology.
[6] K. Bowker,et al. Comparison of the modified Stokes' method of susceptibility testing with results obtained using MIC methods and British Society of Antimicrobial Chemotherapy breakpoints. , 1998, The Journal of antimicrobial chemotherapy.
[7] D. Hughes,et al. Genetic and Phenotypic Identification of Fusidic Acid-Resistant Mutants with the Small-Colony-Variant Phenotype in Staphylococcus aureus , 2007, Antimicrobial Agents and Chemotherapy.
[8] I. Chopra,et al. Distribution of Fusidic Acid Resistance Determinants in Methicillin-Resistant Staphylococcus aureus , 2010, Antimicrobial Agents and Chemotherapy.
[9] T. Morris,et al. Topoisomerase Mutations That Are Associated with High-Level Resistance to Earlier Fluoroquinolones in Staphylococcus aureus Have Less Effect on the Antibacterial Activity of Besifloxacin , 2011, Chemotherapy.
[10] P. Hsueh,et al. Fusidic Acid Resistance Determinants in Staphylococcus aureus Clinical Isolates , 2010, Antimicrobial Agents and Chemotherapy.
[11] K. Walker-Bone,et al. Clinical and Microbiological Determinants of Outcome in Staphylococcus aureus Bacteraemia , 2010, International journal of microbiology.
[12] M. Tanaka,et al. Mechanism of quinolone resistance in Staphylococcus aureus , 2000, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.
[13] A. Myllyniemi,et al. Comparison of Tests for Detection of β-Lactamase-Producing Staphylococci , 2007, Journal of Clinical Microbiology.
[14] D. Hughes,et al. Genetic Determinants of Resistance to Fusidic Acid among Clinical Bacteremia Isolates of Staphylococcus aureus , 2009, Antimicrobial Agents and Chemotherapy.
[15] Ning Ma,et al. BLAST+: architecture and applications , 2009, BMC Bioinformatics.
[16] P. Francioli,et al. Unusual spread of a penicillin-susceptible methicillin-resistant Staphylococcus aureus clone in a geographic area of low incidence. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[17] C. Fishwick,et al. Analysis of mutational resistance to trimethoprim in Staphylococcus aureus by genetic and structural modelling techniques. , 2009, The Journal of antimicrobial chemotherapy.
[18] M. Struelens,et al. Evaluation of the Vitek 2 system for identification and antimicrobial susceptibility testing of Staphylococcus spp. , 2005, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[19] Julian Parkhill,et al. Meticillin-resistant Staphylococcus aureus with a novel mecA homologue in human and bovine populations in the UK and Denmark: a descriptive study , 2011, The Lancet. Infectious diseases.
[20] D. Ince,et al. Mechanisms and Frequency of Resistance to Premafloxacin in Staphylococcus aureus: Novel Mutations Suggest Novel Drug-Target Interactions , 2000, Antimicrobial Agents and Chemotherapy.
[21] Ronald N. Jones,et al. Fusidic Acid Resistance Rates and Prevalence of Resistance Mechanisms among Staphylococcus spp. Isolated in North America and Australia, 2007-2008 , 2010, Antimicrobial Agents and Chemotherapy.
[22] T. Wichelhaus,et al. Molecular analysis of fusidic acid resistance in Staphylococcus aureus , 2003, Molecular microbiology.
[23] Daniel J. Wilson,et al. Whole-Genome Sequencing Shows That Patient-to-Patient Transmission Rarely Accounts for Acquisition of Staphylococcus aureus in an Intensive Care Unit , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[24] G. Dougan,et al. Routine Use of Microbial Whole Genome Sequencing in Diagnostic and Public Health Microbiology , 2012, PLoS pathogens.
[25] B. Barrell,et al. Complete genomes of two clinical Staphylococcus aureus strains: evidence for the rapid evolution of virulence and drug resistance. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[26] G. Kaatz,et al. Mechanisms of fluoroquinolone resistance in genetically related strains of Staphylococcus aureus , 1997, Antimicrobial agents and chemotherapy.
[27] Peter Donnelly,et al. Evolutionary dynamics of Staphylococcus aureus during progression from carriage to disease , 2012, Proceedings of the National Academy of Sciences.
[28] Yasuhiro Suzuki,et al. Detection of mutations in quinolone resistance-determining regions in levofloxacin- and methicillin-resistant Staphylococcus aureus: effects of the mutations on fluoroquinolone MICs. , 2003, Diagnostic microbiology and infectious disease.
[29] L. Peterson,et al. DNA gyrase gyrA mutations in ciprofloxacin-resistant strains of Staphylococcus aureus: close similarity with quinolone resistance mutations in Escherichia coli , 1990, Journal of bacteriology.
[30] J. Andrews. BSAC standardized disc susceptibility testing method (version 8). , 2004, The Journal of antimicrobial chemotherapy.
[31] K. Köhrer,et al. Characterization of grlA, grlB, gyrA, and gyrB Mutations in 116 Unrelated Isolates of Staphylococcus aureus and Effects of Mutations on Ciprofloxacin MIC , 1998, Antimicrobial Agents and Chemotherapy.
[32] T. Nukiwa,et al. Characterization of gyrA, gyrB, grlA and grlB mutations in fluoroquinolone-resistant clinical isolates of Staphylococcus aureus. , 1998, The Journal of antimicrobial chemotherapy.
[33] T. Wichelhaus,et al. Differential effect of rpoB mutations on antibacterial activities of rifampicin and KRM-1648 against Staphylococcus aureus. , 2001, The Journal of antimicrobial chemotherapy.
[34] Daniel J. Wilson,et al. Transforming clinical microbiology with bacterial genome sequencing , 2012, Nature Reviews Genetics.
[35] B. Söderquist,et al. Simultaneous species identification and detection of rifampicin resistance in staphylococci by sequencing of the rpoB gene , 2009, European Journal of Clinical Microbiology & Infectious Diseases.
[36] L. Amaral,et al. Exploring the contribution of efflux on the resistance to fluoroquinolones in clinical isolates of Staphylococcus aureus , 2011, BMC microbiology.
[37] J. Andrews. BSAC WORKING PARTY ON SUSCEPTIBILITY TESTING FT. BSAC STANDARDIZED DISC SUSCEPTIBILITY TESTING METHOD , 2001 .
[38] I. Chopra,et al. Genetic Basis of Resistance to Fusidic Acid in Staphylococci , 2007, Antimicrobial Agents and Chemotherapy.
[39] K. Köhrer,et al. Relationship between ciprofloxacin, ofloxacin, levofloxacin, sparfloxacin and moxifloxacin (BAY 12-8039) MICs and mutations in grlA, grlB, gyrA and gyrB in 116 unrelated clinical isolates of Staphylococcus aureus. , 1998, The Journal of antimicrobial chemotherapy.
[40] A. Anderson,et al. Prospective Screening of Novel Antibacterial Inhibitors of Dihydrofolate Reductase for Mutational Resistance , 2012, Antimicrobial Agents and Chemotherapy.
[41] A. Tomasz,et al. Alternative mutational pathways to intermediate resistance to vancomycin in methicillin-resistant Staphylococcus aureus. , 2013, The Journal of infectious diseases.
[42] Richard G. Everitt,et al. Within-Host Evolution of Staphylococcus aureus during Asymptomatic Carriage , 2013, PloS one.
[43] Martin Goodson,et al. Stampy: a statistical algorithm for sensitive and fast mapping of Illumina sequence reads. , 2011, Genome research.
[44] M. Metzker. Sequencing technologies — the next generation , 2010, Nature Reviews Genetics.
[45] G. Yılmaz,et al. Detection and prevalence of inducible clindamycin resistance in staphylococci. , 2007, Journal of medical microbiology.
[46] L. Peterson,et al. GyrA sequence analysis of Staphylococcus aureus and methicillin-resistant S. aureus strains selected, in vitro, for high-level ciprofloxacin resistance. , 1993, Diagnostic microbiology and infectious disease.
[47] Andrew C. Pawlowski,et al. The Comprehensive Antibiotic Resistance Database , 2013, Antimicrobial Agents and Chemotherapy.
[48] S. Pyörälä,et al. Comparison of phenotypic and genotypic detection of penicillin G resistance of Staphylococcus aureus isolated from bovine intramammary infection. , 2005, Veterinary microbiology.
[49] Daniel J. Wilson,et al. A pilot study of rapid benchtop sequencing of Staphylococcus aureus and Clostridium difficile for outbreak detection and surveillance , 2012, BMJ Open.
[50] T. Ezaki,et al. Emerging multiple mutations and high-level fluoroquinolone resistance in methicillin-resistant Staphylococcus aureus isolated from ocular infections. , 2006, Diagnostic microbiology and infectious disease.
[51] Julian Parkhill,et al. Whole-genome sequencing for analysis of an outbreak of meticillin-resistant Staphylococcus aureus: a descriptive study , 2013, The Lancet. Infectious Diseases.
[52] F. Aarestrup,et al. Diversity and evolution of blaZ from Staphylococcus aureus and coagulase-negative staphylococci. , 2006, The Journal of antimicrobial chemotherapy.
[53] M. Page,et al. A single amino acid substitution in Staphylococcus aureus dihydrofolate reductase determines trimethoprim resistance. , 1997, Journal of molecular biology.
[54] Karen C. Carroll,et al. Evaluation of the BD Phoenix Automated Microbiology System for Identification and Antimicrobial Susceptibility Testing of Staphylococci and Enterococci , 2006, Journal of Clinical Microbiology.
[55] K. Köhrer,et al. Development of Resistance to Ciprofloxacin, Rifampin, and Mupirocin in Methicillin-Susceptible and -ResistantStaphylococcus aureus Isolates , 2000, Antimicrobial Agents and Chemotherapy.
[56] J. Marimón,et al. Epidemiological and molecular aspects of rifampicin-resistant Staphylococcus aureus isolated from wounds, blood and respiratory samples. , 2011, The Journal of antimicrobial chemotherapy.
[57] M. Sasatsu,et al. Susceptibility and resistance genes to fluoroquinolones in methicillin-resistant Staphylococcus aureus isolated in 2002. , 2005, International journal of antimicrobial agents.
[58] D. Persing,et al. Detection of the Staphylococcal mecA gene by chemiluminescent DNA hybridization , 1995, Journal of clinical microbiology.
[59] H. Narita,et al. Mutations in the gyrA and grlA genes of quinolone-resistant clinical isolates of methicillin-resistant Staphylococcus aureus. , 1996, The Journal of antimicrobial chemotherapy.
[60] A. Myllyniemi,et al. Comparison of tests for detection of beta-lactamase-producing staphylococci. , 2007, Journal of clinical microbiology.
[61] R. Howe,et al. BSAC standardized disc susceptibility testing method (version 11). , 2012, The Journal of antimicrobial chemotherapy.
[62] J. R. Johnson,et al. Predicting antimicrobial susceptibilities for Escherichia coli and Klebsiella pneumoniae isolates using whole genomic sequence data , 2013, The Journal of antimicrobial chemotherapy.
[63] Ole Lund,et al. Genotyping using whole-genome sequencing is a realistic alternative to surveillance based on phenotypic antimicrobial susceptibility testing. , 2013, The Journal of antimicrobial chemotherapy.
[64] H. Chen,et al. Fusidic acid resistance among clinical isolates of methicillin-resistant Staphylococcus aureus in a Taiwanese hospital , 2011, BMC Microbiology.